Boston Scientific has proven itself to be a fierce competitor among three major cardiac device makers, with a track record of meaningful innovation and impressive operational chops. Even a prolonged ...

Thanks to healthcare reform, the hurdles to securing reimbursement and technology add-on payments have risen. Boston will need to invest more in clinical studies to demonstrate superiority of outcomes ...

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated ...

Atrial fibrillation is the most common chronic arrhythmia ... When AF occurs, left atrial flow velocities are significantly decreased in the atrium, often with stasis in the left atrial appendage.

Atrial fibrillation (AF), gastroesophageal reflux disease (GERD) and hiatal hernias are commonly seen in clinical practice. GERD and hiatal hernias have been proposed to be a possible cause of AF.

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Atrial fibrillation (AF) and chronic heart failure (CHF) are two major and even growing cardiovascular conditions that often coexist. However, few data are available to guide treatment of AF in ...

A new partnership between virtual ward start-up Doccla, wearable tech company AliveCor, and a UK healthcare trust will examine the care of patients with atrial fibrillation outside of hospital.

Apr. 16, 2025 — Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of ...

Department of Neurology, Medical University of Graz, Austria. (I.H., M. Kneihsl, S.F.-H., C.E., T.G.) Division of Neuroradiology, Vascular and Interventional ...

Background: Recent observational studies in the UK Biobank (UKBB) concluded that self-reported fish oil supplement (FOS) use is associated with an increased risk for incident atrial fibrillation (AF).

AIMS To identify the patent ductus arteriosus (PDA) shunt flow pattern using Doppler echocardiography; and to assess whether it could be used to predict the development of clinically significant PDA.